Last reviewed · How we verify

NCT04405297

A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells

Terminated Last updated 22 October 2025
What this trial tests

trial testing Adipose-derived regenerative cells in Knee Osteoarthritis in 14 participants. Terminated before completion.

Timeline
24 May 2021
Primary endpoint
23 September 2024
23 September 2024

Quick facts

Lead sponsorSanford Health
StatusTerminated
Study typeOBSERVATIONAL
Enrollment14
Start date24 May 2021
Primary completion23 September 2024
Estimated completion23 September 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sanford Health — full company profile →

Who can join

18 and older, any sex, with Knee Osteoarthritis or Hip Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, multi-location safety and effectiveness study, and data registry of autologous adult ADRCs generated by the Transpose® RT System in subjects with OA in the shoulder, wrist, knee, hip, or ankle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Sanford Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04405297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing